Increased Hospitalizations Involving Fungal Infections during COVID-19 Pandemic, United States, January 2020-December 2021.
Emerg Infect Dis
; 29(7): 1433-1437, 2023 07.
Article
en En
| MEDLINE
| ID: mdl-37347805
Hospitalizations involving fungal infections increased 8.5% each year in the United States during 2019-2021. During 2020-2021, patients hospitalized with COVID-19-associated fungal infections had higher (48.5%) in-hospital mortality rates than those with non-COVID-19-associated fungal infections (12.3%). Improved fungal disease surveillance is needed, particularly during respiratory virus pandemics.
Palabras clave
COVID-19; Pneumocystis; SARS; SARS-CoV-2; United States; aspergillosis; blastomycosis; candidiasis; coccidioidomycosis; coronavirus; coronavirus disease; cryptococcosis; fungi; histoplasmosis; hospitalizations; international classification of diseases; invasive fungal infections; mucormycosis; mycoses; pneumonia; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Aspergilosis
/
Blastomicosis
/
Actinomicosis
/
Coccidioidomicosis
/
Criptococosis
/
COVID-19
/
Histoplasmosis
/
Mucormicosis
/
Micosis
/
Nocardiosis
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Emerg Infect Dis
Asunto de la revista:
DOENCAS TRANSMISSIVEIS
Año:
2023
Tipo del documento:
Article